newsmetry
rusign inget started
macro

Inovio wins court judgment of over $80 million against VGXI and GeneOne

A Pennsylvania court ruled for Inovio in its lawsuit against VGXI and GeneOne Life Science, awarding a total of $80,416,101 in damages, fees and costs.

published on Newsmetry
original source published

the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →

Newsmetry newsroom

what happened

Inovio Pharmaceuticals (Nasdaq: INO) said a court in Montgomery County, Pennsylvania, decided in its favor on every claim it brought against VGXI and GeneOne Life Science. The total award comes to $80,416,101. It includes $61,750,789 in compensatory damages and $18,665,312 for legal fees and costs. The court also ruled against the defendants on their counterclaims. Details were reported by TradingView, citing the company's press release, and by Reuters.

The case was filed on June 3, 2020. Inovio argues that the defendants broke their supply agreement by refusing to carry out technology transfer duties needed to scale up production of DNA plasmids. The company says it will make every reasonable effort to recover the money, but it also warned that the defendants' financial condition will likely prevent it from collecting some or all of the award. The judgment could still be reduced, reversed or modified after post-trial motions or an appeal.

why it matters

For the broader market this is mainly a company-level event. The real value of the award depends on whether Inovio can collect it, and the company itself flags that as uncertain. Investors may focus more on the defendants' finances and any appeal than on the headline figure.

tags

SustainabilityRegulationStockUnited States

instruments

INO

sources

  1. INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science — TradingView, 20 October 2026 at 20:05 UTC
  2. Inovio Announces Favorable Judgment In Litigation With Vgxi, Inc. And Geneone Life Science — Reuters, 20 October 2026 at 21:57 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.

get stories in real time ↗

related stories